Sano Genetics raises €9.9M Series A round
28 March 2022· London, United Kingdom· biotechnology, precision_medicine, genomics, b2b, software_hardware
The funding will be used to grow the Sano team in the US and Europe, and develop the platform to meet demand in 50+ diseases and 6+ countries by mid 2023, as well as accelerate personalised medicine research.
Investors
LeadMMC Ventures
Also participating
SeedcampPaul ForsterEpisode 1 VenturesPaul WicksMargo Georgiadis
About Sano Genetics
Stage
Series A
Headquarters
London, United Kingdom
Founded
2017
Team Size
51–200
Sectors
biotechnologyprecision_medicinegenomicsb2bsoftware_hardware